{
  "id": "cluster_9_doc2",
  "content": "Policy memo 2284-QUJ effective April 1, 2023: All dry eye syndrome treatments now require prior authorization. Northstar Specialty Care added to Tier 1 provider network. New biosimilar artificial tear formulations added to formulary. Implementation affects 6,743 patients in the Midwest region. Compliance deadline set for June 30.",
  "metadata": {
    "format": "policy_document"
  }
}